日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice.

GPR4 拮抗剂 NE-52-QQ57 可提高 SARS-CoV-2 感染的 K18-hACE2 转基因小鼠的存活率,减轻过度炎症反应,并降低病毒载量

Wu Xin-Jun, Oppelt Karen A, Fan Ming, Marie Mona A, Swyers Madison M, Williams Ashley J, Lemasson Isabelle M, Roper Rachel L, Bolin Paul, Yang Li V

Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene

细胞内 miR-150-5p 可能通过调控 nsp10 基因在 SARS-CoV-2 感染的生物学过程中发挥关键作用。

Akula, Shaw M; Bolin, Paul; Cook, Paul P

Utilization Patterns and Outcomes of People With Diabetes and COVID-19: Evidence From United States Medicare Beneficiaries in 2020

2020年美国医疗保险受益人糖尿病合并新冠肺炎患者的医疗服务利用模式和结局:证据

Austin, Andrea M; Leggett, Christopher G; Schmidt, Peter; Bolin, Paul; Nelson, Eugene C; Oliver, Brant J; King, Ashleigh C

Racial differences in survival among hemodialysis patients after coronary artery bypass grafting

冠状动脉旁路移植术后血液透析患者的生存率存在种族差异

Efird, Jimmy T; O'Neal, Wesley T; Bolin, Paul Jr; Davies, Stephen W; O'Neal, Jason B; Anderson, Curtis A; Ferguson, T Bruce; Chitwood, W Randolph; Kypson, Alan P